Vaidya Sane Ayurved Laboratories Ltd
Incorporated in 2006, Vaidya Sane Ayurved Laboratories Ltd is the business of running
of hospitals & clinics, and sale of Ayurved based medicines[1]
- Market Cap ₹ 297 Cr.
- Current Price ₹ 283
- High / Low ₹ 294 / 81.1
- Stock P/E 37.1
- Book Value ₹ 59.5
- Dividend Yield 0.00 %
- ROCE 18.4 %
- ROE 13.6 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 4.76 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Working capital days have increased from 22.0 days to 67.8 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|
99.17 | 99.32 | 89.85 | |
90.64 | 93.94 | 76.36 | |
Operating Profit | 8.53 | 5.38 | 13.49 |
OPM % | 8.60% | 5.42% | 15.01% |
1.36 | 1.75 | 0.66 | |
Interest | 0.86 | 1.12 | 0.10 |
Depreciation | 2.60 | 3.14 | 4.16 |
Profit before tax | 6.43 | 2.87 | 9.89 |
Tax % | 24.88% | 30.31% | 27.70% |
4.83 | 1.98 | 7.14 | |
EPS in Rs | 4.59 | 1.88 | 6.79 |
Dividend Payout % | 5.44% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -10% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 360% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 27% |
1 Year: | 89% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | 14% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|
Equity Capital | 10.51 | 10.51 | 10.52 |
Reserves | 29.94 | 45.09 | 52.02 |
0.13 | 1.68 | 1.46 | |
14.30 | 13.61 | 12.71 | |
Total Liabilities | 54.88 | 70.89 | 76.71 |
20.95 | 28.02 | 34.92 | |
CWIP | 1.67 | 2.60 | 0.00 |
Investments | 15.33 | 3.22 | 21.32 |
16.93 | 37.05 | 20.47 | |
Total Assets | 54.88 | 70.89 | 76.71 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|
0.06 | -4.41 | 10.60 | |
0.52 | 1.49 | -10.08 | |
-1.38 | 14.46 | -0.54 | |
Net Cash Flow | -0.80 | 11.55 | -0.01 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|
Debtor Days | 22.05 | 26.31 | 30.63 |
Inventory Days | 81.93 | ||
Days Payable | 149.49 | ||
Cash Conversion Cycle | 22.05 | 26.31 | -36.92 |
Working Capital Days | -2.39 | 0.66 | 67.84 |
ROCE % | 7.44% | 18.45% |
Documents
Announcements
-
Shareholders meeting
25 August 2025 - 25 Aug 2025 EGM approved authorised capital increase and preferential convertible warrants; 459,450 votes for.
-
Shareholders meeting
25 August 2025 - 25 Aug 2025 EGM approved authorised capital increase and preferential convertible warrants issuance.
-
General Updates
25 August 2025 - Corrigendum: Preferential issue 56,00,000 warrants at INR183 each (INR102.48 crore); EGM 25 Aug 2025.
-
Analysts/Institutional Investor Meet/Con. Call Updates
16 August 2025 - Virtual investor/analyst meeting scheduled for 20th August 2025 at 4 pm.
-
General Updates
5 August 2025 - EGM notice for August 25, 2025, and multiple debt recovery auction details published as per SEBI norms.
Annual reports
Concalls
-
May 2025Transcript PPT
-
Nov 2024TranscriptPPT
-
Jun 2024Transcript PPT
-
May 2024TranscriptNotesPPT
-
Nov 2023TranscriptNotesPPT
-
Nov 2023Transcript PPT REC
-
Nov 2023Transcript PPT
-
May 2023TranscriptNotesPPT
-
Nov 2022TranscriptNotesPPT
Business Overview[1]
Vaidya Sane Ayurved Laboratories Ltd (Madhavbaug) is among India’s leading chains of cardiac care clinics and hospitals, specializing in non-invasive, Ayurveda-based treatments for chronic conditions like heart disease, diabetes, hypertension, obesity, and joint pain. The company combines traditional medicine with modern diagnostics and technology, supported by in-house manufacturing of Ayurvedic medicines and nutritional products.